FIM
ATHE

Freedom Investment Management’s Alterity Therapeutics ATHE Stock Holding History

Freedom Investment Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-462
Closed -$194K – 435
2013
Q4 		$194K Buy
+462
New +$138K 0.05% 400

Other funds holding ATHE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Freedom Investment Management's ATHE Position: Q1 2014 in Review

Freedom Investment Management sold out of Alterity Therapeutics (ATHE) in Q1 2014, closing a stake of 462 shares — an estimated $194K sold.

Freedom Investment Management first reported a position in ATHE in Q4 2013 and held it in 1 quarter. The position peaked at $194K in Q4 2013. 29 funds tracked by Wall St. Rank hold ATHE as of Q1 2014.

  • Freedom Investment Management reported no remaining Alterity Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Freedom Investment Management sold 462 Alterity Therapeutics shares in Q1 2014, an estimated $194K.
  • Freedom Investment Management first reported a position in Alterity Therapeutics in Q4 2013 and held it in 1 quarter.
  • Freedom Investment Management's Alterity Therapeutics position peaked at $194K in Q4 2013.
  • 29 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2014.

Based on Freedom Investment Management's 13F filing for Q1 2014, filed 14 May 2014.